Posts Tagged ‘catheter’

CCI 16.0 Bundles EP Study with Ablations in Error

Thursday, February 25th, 2010

If your first reaction to January’s Correct Coding Initiative (CCI) edits bundling catheter ablations with electrophysiology (EP) studies was, “This has got to be a mistake!” you were right. You can expect the edits to be retroactively deleted in the quarterly update to CCI edits, version 16.1.

Bungled Bundle

According to a Coding News report, CCI version 16.0 bundles the following with atrioventricular (AV) ablation code 93650:

  • Recording codes 93602 and 93603
  • Pacing codes 93610, 93612, 93618, and 93623
  • EP Study codes 93619, 93620-93622

You’ll also find pacing codes 93610 and 93612 bundled with supraventricular tachycardia (SVT) ablation code 93651;  and ventricular tachycardia (VT) ablation code 93652 bundled with the following:

  • Bundle of His recording code 93600
  • Recording codes 93602 and 93603
  • Pacing codes 93610, 93612 nd 93618

These code pair edits were assigned a modifier indicator of “0,” according to a Heart Rhythm Society report, meaning they cannot be overridden.

Interim Solution

Until version 16.1 edits go into effect, you have two choices for how to handle claims. The Centers for Medicare & Medicaid Services (CMS) suggests that you delay submission of claims that include the bundled code pairs until after version 16.1 goes into effect. Can’t afford the loss of quarterly revenue? Alternatively, you can submit claims as usual and then resubmit claims for denied services after April 1 when the retroactive deletion will appear in the claims processing contractor CCI files.

Resource: Download the latest CCI edits from the CMS website.

FDA Recalls CardioVations EndoClamp Aortic Catheter

Monday, November 16th, 2009

The U.S. Food and Drug Administration (FDA) and Edwards Lifesciences notified health care professionals, Nov. 9, about the Class 1 recall of CardioVations EndoClamp™ Aortic Catheter, model numbers EC1001 and EC65. The recall was initiated because the balloon catheters may spontaneously rupture during surgery.

This product was manufactured from August 2008 through August 2009 and distributed from November 2008 through September 2009.

The device blocks off the aorta, monitors aortic pressure, and delivers solution to stop the heart during cardiopulmonary bypass procedures.

On Oct. 29, 2009, the manufacturer sent a follow-up letter to their customers instructing them to:

  • Check their inventory and identify any unused product; and 
  • Return unused products to the company.

Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the product will cause serious adverse health consequences or death.

Health care professionals and consumers may report adverse reactions or quality problems experienced with the use of this product to the FDA’s MedWatch Adverse Event Reporting program.

Catheter Codes Cause Confusion

Monday, November 2nd, 2009

National Heritage Insurance Company (NHIC) issued a notification update Oct. 14 to clarify its coding and utilization guidelines for certain male external catheters supplied to Medicare beneficiaries.

Read more »

Fistula First Breakthrough Initiative Provides Roadmap to Reach Goal of 66%

Monday, November 2nd, 2009

The Fistula First Breakthrough Initiative (FFBI) has released a strategic plan for achieving the Center for Medicare & Medicaid Services’ (CMS) goal that two-thirds (66 percent) of prevalent hemodialysis patients will use an arteriovenous (AV) fistula as their primary method of vascular access. Read more »

Ablation Catheters for Atrial Fibrillation Approved

Friday, February 13th, 2009

The U.S. Food and Drug Administration (FDA) announced, Feb. 6, that it has approved the first ablation catheters—BioSense Webster’s NaviStar ThermoCool and the EZ Steer ThermoCool Nav—for the treatment of atrial fibrillation (AF).

Read more »

OIG Reports on Adverse Event Study

Monday, January 5th, 2009

Fifteen percent of hospitalized Medicare beneficiaries in two selected counties experienced an adverse event during their hospital stays, the Office of the Inspector General (OIG) said in a Dec. 19, 2008 report. Read more »